Microprofit Biotech Showcases Chinese Manufacturing Excellence at MEDICA 2023

The MEDICA 2023 unfolded in grandeur at the Düsseldorf Exhibition Centre from November 13 to 16, solidifying its position as the premier global comprehensive medical equipment exhibition in scale and influence. Among the distinguished participants was Microprofit Biotech, a prominent player in the field of in-vitro diagnostics in China, presenting its FIA Quantitative POCT Platform， Respiratory Viruses Rapid Test Solution, STDs Immunofluorescence Test Solution and Digital Mammography System.

Microprofit Biotech, standing shoulder to shoulder with over 5,500 enterprises from more than 70 countries and regions worldwide, showcased its innovative products at this prestigious event. As a old exhibitor in the field of in-vitro diagnostics, Microprofit Biotech warmly welcomed representatives, distributors, doctors, and scholars from across the globe with unmatched enthusiasm.

The highlight of the exhibition was Microprofit Biotech's independently developed Respiratory Viruses Rapid Test Solution. This groundbreaking solution provides accurate and reliable results for individuals grappling with respiratory virus infections. Visitors at the exhibition were captivated by the fluorecare® FIA Quantitative POCT Platform developed by Microprofit Biotech, drawn to their richness, speed, and accuracy. The company's on-site staff provided detailed explanations of product usage, helping visitors gain a deeper understanding of the features and applications of these innovative diagnostic tools.

With over 14 years of dedicated research in the field of in-vitro diagnostics, Microprofit Biotech has consistently pursued independent research and development, overcoming numerous technological challenges and breaking through core technical barriers. Currently holding more than 40 invention patents and over 150 CE certifications, the company's robust scientific research capabilities and exceptional product quality have enabled its partners to span across 100+ countries and regions globally.
The MEDICA 2023 exhibition undoubtedly serves as a new window for Microprofit Biotech's global brand promotion and product showcase. Looking ahead, the company aims to collaborate with more partners to continually contribute to the development of China's healthcare industry and provide the world with an array of medical and health solutions.